Purpose: The purpose of this study was to compare the effect of treating skeletal muscle cells with media 26 conditioned by postprandial ex vivo human serum fed with either isonitrogenous NEAA or a whey protein 27 hydrolysate (WPH) on stimulating MPS in C2C12 skeletal muscle cells. Methods: Blood was taken from six 28 young healthy males following overnight fast (fasted) and 60 min postprandial (fed) ingestion of either WPH or 29 NEAA (0.33 g.kg -1 Body Mass). C2C12 myotubes were treated with media conditioned by ex vivo human serum 30 (20%) for 4 h. Activation of MPS signalling (phosphorylation of mTOR, P70S6K and 4E-BP1) were determined 31 in vitro by Western Blot and subsequent de novo MPS were determined in vitro by Western Blot and surface 32 sensing of translation technique (SUnSET) techniques, respectively. Results: Media conditioned by NEAA fed 33 serum had no effect on protein signalling or MPS compared to fasted, whereas media conditioned by WPH fed 34 serum significantly increased mTOR, P70S6K and 4E-BP1 phosphorylation (p<0.01, p<0.05) compared to fasted 35 serum. Furthermore, the effect of media conditioned by WPH fed serum on protein signalling and MPS was 36 significantly increased (p<0.01, p<0.05) compared to NEAA fed serum. Conclusion: In summary, media
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Ingestion of ~ 0.33g.kg -1 body mass whey protein results in post-ingestion aminoacidaemia and an increase in 74 circulating EAA of approximately 3-fold within 60 min (18) . Though equivocal, it seemed plausible to suggest 75 the augmented MPS response of myotubes exposed to 'fed' vs. 'fasted' serum conditioned media was due to the 76 increase in circulating EAA in fed serum and that a similar aminoacidaemia through increase in [NEAA] would 77 not result in an increase in MPS. To test this hypothesis, we fed a NEAA formulation designed by Norton et al.
78
(in review), isonitrogenous to whey protein, to human participants. Using the C2C12 in vitro model established 79 previously (18), serum sampled pre-and post-feeding was used to condition media of C2C12 myotubes to evaluate 
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Cells treated with media conditioned by WPH-fed serum observed significantly increased mTOR activation 166 (p<0.01) (Figure 1) relative to its corresponding fasted serum (Figure 1A, 1B) . This increase in mTOR activation 167 was consistently observed in serum from each participant (n=6) (Figure 1A) . In comparison, NEAA-fed serum 168 did not activate mTOR (Figure 1) which remained at a similar level to its corresponding fasted serum ( Figure   169   1A, 1B) . Furthermore, when normalised to corresponding fasted serum (Figure 1B) (Figure 2) . Like mTOR, P70S6K (Figure 2A, 2B) and 4E-181 BP1 (Figure 2C, 2D) activation was significantly increased (p<0.05) in the WPH-fed condition relative to its 182 corresponding fasted serum. Comparatively, no change in P70S6K (Figure 2A, 2B) or 4E-BP1 (Figure 2C, 2D) 183 phosphorylation relative to fasted, following treatment with media conditioned by NEAA-fed serum was evident.
184
This was consistently observed in each participant (Figure 2A, 2C) . A significant increase (p<0.05) in P70S6K
185
( Figure 2B) and 4E-BP1 (Figure 2D) 
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The importance of the use of appropriate negative controls in human MPS studies has recently been emphasised 212 by key opinion leaders in the field (5, 6). Many studies in these meta-analyses report on the effects of amino acid 213 and protein supplementation on MPS in humans which use less appropriate controls (5, 7, 8) . In line with the 214 scientific opinion of EFSA, that human intervention studies assessing the effect of different proteins on 215 physiological processes require an isonitrogenous comparator, a NEAA-only containing formulation 216 isonitrogenous to whey protein, was fed to human participants in equal dose to a whey protein hydrolysate. Fed 217 and fasted serum was used to condition media of C2C12 myotubes and evaluate change in intracellular signalling 218 and de novo MPS. Our findings show that media conditioned by WPH-fed serum stimulated kinases of the mTOR 219 pathway and MPS in vitro, however media conditioned by NEAA-fed serum did not.
221
As expected, plasma EAA concentration, including leucine, were not significantly elevated from fasting levels 222 following NEAA ingestion, but were increased following WPH ingestion ( Table 2) . Elevated plasma levels of 223 EAA post protein feeding have previously been shown to robustly increase MPS (15, 26) . Rennie and colleagues 224 reported that an increase of ~80 µmol/L in extracellular leucine is required to increase MPS in vivo (27, 28) . Here,
225
we observed an increase greater than ~200µmol/L for WPH-fed, however, this threshold was not reached in
226
NEAA-fed condition and likely explains the lack of activation of MPS in our model, confirming NEAA as an 227 effective isonitrogenous non-bioactive control.
228
Several humoral factors may act individually or collectively to stimulate MPS. Whereas circulating EAA are 229 thought to be the primary drivers of MPS, protein ingestion has been shown to induce an increase in insulin, which 230 is deemed 'permissive' with respect to MPS (29) . In this study, we report a small increase (~40 -45%) in 231 circulating insulin with ingestion of both WPH and NEAA. As reviewed elsewhere (30) (Figure 1A, 2A, 2C) , normalised relative to fasted 250 serum (Figure 1B, 2B, 2D) and in comparison to NEAA-fed. These in vitro data confirm the bioactivity of WPH 251 to activate MPS. Furthermore, activation of mTOR, P70S6K and 4E-BP1 with media conditioned by WPH-fed 252 serum resulted in significantly greater stimulation of de novo MPS than media conditioned by NEAA-fed serum 253 (Figure 3B) , providing further validation of the NEAA formulation used in this study as an isonitrogenous, non-254 bioactive control.
255
In this study, we have demonstrated that an isonitrogenous NEAA supplement can be used as a non-bioactive 256 control for MPS in protein feeding studies. As discussed, NEAA have previously been demonstrated not to be 257 primarily responsible or required to stimulate MPS (1-3, 17) . Similarly, unlike a bioactive WPH supplement, the 258 isonitrogenous non-bioactive NEAA control used here did not alter protein signalling activity of mTOR, P70S6K 259 and 4E-BP1 or MPS levels relative to its corresponding fasted serum. This suggests that in acute feeding studies, 260 this isonitrogenous non-bioactive NEAA supplement can serve as an appropriate control. 
